INFLUENCE OF THE HIGH-AFFINITY GROWTH-HORMONE (GH) BINDING-PROTEIN ON PLASMA PROFILES OF FREE AND BOUND GH AND ON THE APPARENT HALF-LIFE OF GH - MODELING ANALYSIS AND CLINICAL-APPLICATIONS

被引:96
作者
VELDHUIS, JD
JOHNSON, ML
FAUNT, LM
MERCADO, M
BAUMANN, G
机构
[1] UNIV VIRGINIA,HLTH SCI CTR,DEPT PHARMACOL,CHARLOTTESVILLE,VA 22908
[2] NATL SCI FDN,CTR BIOL TIMING,CHARLOTTESVILLE,VA 22908
[3] NORTHWESTERN UNIV,SCH MED,DEPT MED,CTR ENDOCRINOL METAB & NUTR,CHICAGO,IL 60611
关键词
DIABETES-MELLITUS; GROWTH HORMONE; LARON DWARFISM; OBESITY;
D O I
10.1172/JCI116243
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The discovery of a specific high-affinity growth hormone (GH) binding protein (GH-BP) in plasma adds complexity to the dynamics of GH secretion and clearance. Intuitive predictions are that such a protein would damp sharp oscillations in GH concentrations otherwise caused by bursts of GH secretion into the blood volume, prolong the apparent half-life of circulating GH, and contribute a reservoir function. To test these implicit considerations, we formulated an explicit mathematical model of pulsatile GH secretion and clearance in the presence or absence of a specific high-affinity GH-BP. Simulation experiments revealed that the pulsatile mode of physiological GH secretion creates a highly dynamic (nonequilibrium) system, in which the half-life of free GH, its instantaneous secretion rate, and the GH-BP affinity and capacity all contribute to defining momentary levels of free, bound, and total GH; the percentage of GH bound to protein; and the percentage occupancy of GH-BP. In contrast, the amount of free GH at equilibrium is specified only by the GH distribution volume and secretion rate and the half-life of free hormone. We conclude that the in vivo dynamics of GH secretion, trapping, and clearance from the circulation offer a variety of regulatory loci at which the time structure of free, bound, and total GH delivery to target tissues can be controlled physiologically.
引用
收藏
页码:629 / 641
页数:13
相关论文
共 53 条
[1]   CHARACTERIZATION OF THE GROWTH HORMONE-BINDING PROTEIN OF HUMAN-SERUM USING A PANEL OF MONOCLONAL-ANTIBODIES [J].
BARNARD, R ;
QUIRK, P ;
WATERS, MJ .
JOURNAL OF ENDOCRINOLOGY, 1989, 123 (02) :327-332
[2]   SIMPLE ALGEBRAIC AND GRAPHIC METHODS FOR THE APPORTIONMENT OF HORMONE (AND RECEPTOR) INTO BOUND AND FREE FRACTIONS IN BINDING EQUILIBRIA - OR HOW TO CALCULATE BOUND AND FREE HORMONE [J].
BARSANO, CP ;
BAUMANN, G .
ENDOCRINOLOGY, 1989, 124 (03) :1101-1106
[3]   GROWTH-HORMONE HETEROGENEITY - GENES, ISOHORMONES, VARIANTS, AND BINDING-PROTEINS [J].
BAUMANN, G .
ENDOCRINE REVIEWS, 1991, 12 (04) :424-449
[4]   IMMUNOCHEMICAL SIMILARITY OF THE HUMAN-PLASMA GROWTH HORMONE-BINDING PROTEIN AND THE RABBIT LIVER GROWTH-HORMONE RECEPTOR [J].
BAUMANN, G ;
SHAW, MA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (02) :573-578
[5]   THE MOLECULAR NATURE OF CIRCULATING GROWTH-HORMONE IN NORMAL AND ACROMEGALIC MAN - EVIDENCE FOR A PRINCIPAL AND MINOR MONOMERIC FORMS [J].
BAUMANN, G ;
MACCART, JG ;
AMBURN, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (05) :946-952
[6]   ABSENCE OF THE PLASMA GROWTH HORMONE-BINDING PROTEIN IN LARON-TYPE DWARFISM [J].
BAUMANN, G ;
SHAW, MA ;
WINTER, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (04) :814-816
[7]   A SPECIFIC GROWTH HORMONE-BINDING PROTEIN IN HUMAN-PLASMA - INITIAL CHARACTERIZATION [J].
BAUMANN, G ;
STOLAR, MW ;
AMBURN, K ;
BARSANO, CP ;
DEVRIES, BC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (01) :134-141
[8]   A 2ND, LOWER AFFINITY GROWTH HORMONE-BINDING PROTEIN IN HUMAN PLASMA [J].
BAUMANN, G ;
SHAW, MA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (03) :680-686
[9]   LOW-LEVELS OF HIGH-AFFINITY GROWTH-HORMONE BINDING-PROTEIN IN AFRICAN PYGMIES [J].
BAUMANN, G ;
SHAW, MA ;
MERIMEE, TJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) :1705-1709
[10]   REGULATION OF PLASMA GROWTH HORMONE-BINDING PROTEINS IN HEALTH AND DISEASE [J].
BAUMANN, G ;
SHAW, MA ;
AMBURN, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (07) :683-689